- PMID: 35698903
- DOI: 10.2217/pgs-2022-0027
- Article on PubMed.gov
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update
- PMID: 35034351
- DOI: 10.1002/cpt.2526
- Article on PubMed.gov
Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions
- PMID: 35396982
- DOI: 10.1016/j.gim.2022.03.005
Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States
- PMID: 35436997
- DOI: 10.1038/s41397-022-00277-5
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension
- PMID: 35660539
- DOI: 10.1016/j.cct.2022.106813
Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study
Affiliations
- PMID: 35331649
- DOI: 10.1016/j.gim.2022.01.022
Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial
Nadkarni, G. N., Fei, K., Ramos, M. A., Hauser, D., Bagiella, E., Ellis, S. B., Sanderson, S., Scott, S. A., Sabin, T., Madden, E., Cooper, R., Pollak, M., Calman, N., Bottinger, E. P., & Horowitz, C. R.